1. Home
  2. CIX vs AGMB Comparison

CIX vs AGMB Comparison

Compare CIX & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CompX International Inc.

CIX

CompX International Inc.

SELL

Current Price

$37.63

Market Cap

484.3M

ML Signal

SELL

Logo AgomAb Therapeutics NV American Depositary Shares

AGMB

AgomAb Therapeutics NV American Depositary Shares

SELL

Current Price

$8.44

Market Cap

576.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CIX
AGMB
Founded
1993
2017
Country
United States
Belgium
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
484.3M
576.2M
IPO Year
1997
2024

Fundamental Metrics

Financial Performance
Metric
CIX
AGMB
Price
$37.63
$8.44
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $37.67
AVG Volume (30 Days)
26.6K
★ 139.5K
Earning Date
11-04-2026
11-14-2026
Dividend Yield
★ 5.90%
N/A
EPS Growth
★ 17.04
N/A
EPS
★ 1.06
N/A
Revenue
★ $158,285,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$35.17
★ N/A
Revenue Growth
★ 8.46
N/A
52 Week Low
$20.29
$7.97
52 Week High
$40.30
$17.82

Technical Indicators

Market Signals
Indicator
CIX
AGMB
Relative Strength Index (RSI) 44.20 31.21
Support Level $23.34 N/A
Resistance Level $40.29 $12.53
Average True Range (ATR) 1.35 0.81
MACD -0.46 0.01
Stochastic Oscillator 8.18 13.95

Price Performance

Historical Comparison
CIX
AGMB

About CIX CompX International Inc.

Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's reportable operating segment includes Security Products and Marine Components. It generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.

About AGMB AgomAb Therapeutics NV American Depositary Shares

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.

Share on Social Networks: